Augustine Asset Management Inc. decreased its stake in shares of Monsanto Company (NYSE:MON) by 0.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,933 shares of the basic materials company’s stock after selling 161 shares during the period. Monsanto comprises about 1.5% of Augustine Asset Management Inc.’s investment portfolio, making the stock its 27th largest position. Augustine Asset Management Inc.’s holdings in Monsanto were worth $2,359,000 at the end of the most recent quarter.
A number of other large investors also recently made changes to their positions in the stock. Exane Asset Management bought a new stake in shares of Monsanto during the second quarter valued at about $23,614,000. Aperio Group LLC raised its stake in shares of Monsanto by 13.8% in the second quarter. Aperio Group LLC now owns 195,155 shares of the basic materials company’s stock valued at $23,099,000 after buying an additional 23,731 shares during the last quarter. Visionary Asset Management Inc. bought a new stake in shares of Monsanto during the second quarter valued at about $202,000. Louisiana State Employees Retirement System raised its stake in shares of Monsanto by 1.1% in the second quarter. Louisiana State Employees Retirement System now owns 27,200 shares of the basic materials company’s stock valued at $3,219,000 after buying an additional 300 shares during the last quarter. Finally, Nisa Investment Advisors LLC raised its stake in shares of Monsanto by 8.9% in the second quarter. Nisa Investment Advisors LLC now owns 201,052 shares of the basic materials company’s stock valued at $23,774,000 after buying an additional 16,500 shares during the last quarter. Institutional investors and hedge funds own 75.28% of the company’s stock.
Monsanto Company (NYSE MON) traded down 0.20% during midday trading on Friday, reaching $116.87. 2,081,472 shares of the company were exchanged. Monsanto Company has a 52 week low of $97.35 and a 52 week high of $118.97. The firm has a market capitalization of $51.34 billion, a PE ratio of 25.24 and a beta of 1.07. The company has a 50-day moving average of $117.38 and a 200 day moving average of $115.36.
Monsanto (NYSE:MON) last issued its quarterly earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. The company had revenue of $4.23 billion during the quarter, compared to the consensus estimate of $4.18 billion. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. Monsanto’s revenue was up 1.0% on a year-over-year basis. During the same period last year, the company earned $2.17 earnings per share. Equities analysts predict that Monsanto Company will post $4.89 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be given a $0.54 dividend. The ex-dividend date of this dividend is Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.85%. Monsanto’s dividend payout ratio is presently 46.75%.
Several equities research analysts have issued reports on the stock. BidaskClub upgraded shares of Monsanto from a “sell” rating to a “hold” rating in a research report on Saturday. UBS AG lowered shares of Monsanto from a “buy” rating to a “neutral” rating in a research report on Friday. Piper Jaffray Companies set a $128.00 target price on shares of Monsanto and gave the company a “buy” rating in a research report on Friday, August 11th. Vetr lowered shares of Monsanto from a “buy” rating to a “hold” rating and set a $122.35 target price for the company. in a research report on Wednesday, August 2nd. Finally, Royal Bank Of Canada reiterated a “hold” rating and set a $128.00 target price on shares of Monsanto in a research report on Wednesday, August 2nd. One investment analyst has rated the stock with a sell rating, twelve have issued a hold rating and eight have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $123.15.
In other news, EVP Robert T. Fraley sold 52,410 shares of Monsanto stock in a transaction on Monday, July 10th. The stock was sold at an average price of $117.95, for a total transaction of $6,181,759.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Janet M. Holloway sold 7,423 shares of Monsanto stock in a transaction on Tuesday, June 13th. The stock was sold at an average price of $118.00, for a total value of $875,914.00. Following the sale, the senior vice president now owns 33,645 shares of the company’s stock, valued at $3,970,110. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 74,470 shares of company stock valued at $8,791,281. 0.79% of the stock is owned by corporate insiders.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.